Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.28 +0.02 (+7.69%)
At close: Nov 6, 2026 · 4:00 PM EST

Anebulo Pharmaceuticals (ANEB) Other financing activities (as filed) (2023)

Updated

Anebulo Pharmaceuticals (ANEB) posted Other financing activities of $116,664 for FY2025 (year ended Jun 30, 2025), up 87.1% from $62,354 in FY2024.

Analysis

Anebulo Pharmaceuticals (ANEB) Other financing activities (as filed) (2023) Analysis & Trends

  • Business Quant data shows ANEB's Other financing activities at $62,354 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Anebulo Pharmaceuticals 11.50 Mn -32.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -68,156.00
API Access

Anebulo Pharmaceuticals Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ANEB&period=max&api_key=YOUR_API_KEY